Andrea L. Kasinski, Ph.D.

Affiliations: 
2009 Biological and Biomedical Sciences Emory University, Atlanta, GA 
Area:
Oncology, Pharmacology, Genetics
Google:
"Andrea Kasinski"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Haian Fu grad student 2009 Emory
 (Targeting cell survival signaling for therapeutic discovery.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Puckett MC, Goldman EH, Cockrell LM, et al. (2022) Correction for Puckett et al., "Integration of Apoptosis Signal-Regulating Kinase 1-Mediated Stress Signaling with the Akt/Protein Kinase B-IκB Kinase Cascade". Molecular and Cellular Biology. e0028222
Pal AS, Bains M, Agredo A, et al. (2020) Identification of microRNAs that promote erlotinib resistance in non-small cell lung cancer. Biochemical Pharmacology. 114154
Orellana EA, Li C, Lisevick A, et al. (2019) Identification and validation of microRNAs that synergize with miR-34a - a basis for combinatorial microRNA therapeutics. Cell Cycle (Georgetown, Tex.). 1-14
Zhou W, Pal AS, Hsu AY, et al. (2018) MicroRNA-223 Suppresses the Canonical NF-κB Pathway in Basal Keratinocytes to Dampen Neutrophilic Inflammation. Cell Reports. 22: 1810-1823
Pal AS, Kasinski AL. (2017) Animal Models to Study MicroRNA Function. Advances in Cancer Research. 135: 53-118
Orellana EA, Tenneti S, Rangasamy L, et al. (2017) FolamiRs: Ligand-targeted, vehicle-free delivery of microRNAs for the treatment of cancer. Science Translational Medicine. 9
Gilbert-Ross M, Konen J, Koo J, et al. (2017) Targeting adhesion signaling in KRAS, LKB1 mutant lung adenocarcinoma. Jci Insight. 2: e90487
Pal AS, Agredo A, Kasinski AL. (2017) Abstract 3142: Aberrantly expressed microRNAs drive the development of acquired Erlotinib resistance in non-small cell lung cancer Cancer Research. 77: 3142-3142
Kasinski AL, Kelnar K, Stahlhut C, et al. (2015) A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer. Oncogene. 34: 3547-55
Adams BD, Kasinski AL, Slack FJ. (2014) Aberrant regulation and function of microRNAs in cancer. Current Biology : Cb. 24: R762-76
See more...